Tang Capital Management’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.19M	Sell	1,886,748 -837,761	-31%	-$1.49M	0.16%	43
2025 Q4	$3.87M	Sell	2,724,509 -2,372,853	-47%	-$3.46M	0.19%	61
2025 Q3	$8.36M	Hold	5,097,362	–	–	0.32%	70
2025 Q2	$3.73M	Hold	5,097,362	–	–	0.19%	96
2025 Q1	$4.11M	Buy	5,097,362 +1,447,362	+40%	+$1.67M	0.23%	80
2024 Q4	$5.04M	Buy	3,650,000 +1,300,000	+55%	+$1.46M	0.33%	71
2024 Q3	$2.44M	Buy	2,350,000 +1,300,000	+124%	+$1.78M	0.17%	93
2024 Q2	$1.82M	Buy	+1,050,000	New	+$2.11M	0.19%	80
2023 Q4	–	Sell	-400,000	Closed	-$1.5M	–	125
2023 Q3	$1.5M	Hold	400,000	–	–	0.21%	83
2023 Q2	$1.71M	Buy	400,000 +200,000	+100%	+$1.18M	0.25%	74
2023 Q1	$1.37M	Buy	200,000 +84,100	+73%	+$653K	0.2%	75
2022 Q4	$918K	Sell	115,900 -634,100	-85%	-$4.88M	0.13%	69
2022 Q3	$7.21M	Hold	750,000	–	–	0.88%	34
2022 Q2	$5.43M	Hold	750,000	–	–	0.82%	31
2022 Q1	$9.68M	Buy	750,000 +100,000	+15%	+$1.27M	1.96%	13
2021 Q4	$10.4M	Hold	650,000	–	–	2.09%	13
2021 Q3	$10.4M	Hold	650,000	–	–	2.17%	11
2021 Q2	$8.99M	Hold	650,000	–	–	1.79%	8
2021 Q1	$9.5M	Hold	650,000	–	–	2.67%	7
2020 Q4	$11.3M	Buy	650,000 +100,000	+18%	+$1.78M	1.72%	6
2020 Q3	$10.1M	Hold	550,000	–	–	1.83%	12
2020 Q2	$9.82M	Buy	550,000 +200,000	+57%	+$3.39M	0.96%	14
2020 Q1	$5.68M	Buy	+350,000	New	+$6.47M	0.8%	14